BPG is committed to discovery and dissemination of knowledge
Featured Articles
7/14/2017 7:32:19 AM | Browse: 206 | Download: 240
Publication Name World Journal of Gastrointestinal Oncology
Manuscript ID 33138
Country of Manuscript Source Canada
2017-02-06 18:24
Peer-Review Started
2017-02-12 17:47
To Make the First Decision
2017-03-06 18:13
Return for Revision
2017-03-07 15:03
2017-03-21 05:01
Second Decision
2017-04-10 18:29
Accepted by Journal Editor-in-Chief
2017-04-11 17:36
Accepted by Company Editor-in-Chief
2017-04-19 16:39
Articles in Press
2017-04-19 16:39
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2017-07-04 01:40
Publish the Manuscript Online
2017-07-12 06:47
ISSN 1948-5204 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA
Website http://www.wjgnet.com
Specialty Gastroenterology and Hepatology
Manuscript Type Review
Article Title Evolving treatment landscape for early and advanced pancreatic cancer
Manuscript Source Invited Manuscript
All Author List Sally C Lau and Winson Y Cheung
Funding Agency and Grant Number
Correspondence To Dr. Winson Y Cheung, Department of Oncology, University of Calgary, Tom Baker Cancer Center, 1331 29 ST NW, Calgary, AB T2N 4N2, Canada. wcheung@bccancer.bc.ca
Keywords Cancer; Neoplasm; Pancreas; Adjuvant treatment; Systemic treatment; Gemcitabine; FOLFIR­INOX; Nab-paclitaxel
Core Tip Pancreatic ductal adenocarcinoma is an infrequent cancer with high disease mortality. The focus on management of the disease has been mainly palliation for the past decade. Recently, the discovery of active multi-agent chemotherapies such as FOLFIRINOX and gemcitabine plus nab-paclitaxel has changed the management of the disease. In our current review, we will highlight some of the advances, particularly with respect to systemic therapy options, in the management of different stages of pancreatic cancer.
Publish Date 2017-07-12 06:47
Citation Lau SC, Cheung WY. Evolving treatment landscape for early and advanced pancreatic cancer. World J Gastrointest Oncol 2017; 9(7): 281-292
Url http://www.wjgnet.com/1948-5204/full/v9/i7/281.htm
DOI http://dx.doi.org/10.4251/wjgo.v9.i7.281
Full Article (PDF) WJGO-9-281.pdf
Full Article (Word) WJGO-9-281.doc
Revised Manuscript 33138-Review.docx
Peer-review Report 33138-Peer-review(s).pdf
Journal Editor-in-Chief Review Report 33138-Journal editor-in-chief review report.pdf
Answering Reviewers 33138-Answering reviewers.pdf
Scientific Misconduct Check 33138-Scientific misconduct check.pdf
Scientific Editor Work List 33138-Scientific editor work list.pdf
Audio Core Tip 33138-Audio core tip.mp3
Conflict-of-Interest Disclosure Form 33138-Conflict-of-interest statement.pdf
Copyright License Agreement 33138-Copyright assignment.pdf